US$ 27.78
glp-1 for bulimia New hope binge eating and bulimia: drugs could be the key GLP-1 Therapy: An Emerging Tool
Description
Nat Med 17:14811489

ClinicalTrials.gov (2024)

In India, private equity firm Advent International has invested about $2 billion in buying a string of companies over the last five years and clubbing them under the umbrella CDMO brand Cohance Lifesciences

Their impact is being felt across regions and across categories, but the effect in one sector isnt always mirrored in another
